Literature DB >> 11186471

Nephrotoxicity related to contrast media.

K J Berg1.   

Abstract

The numbers of contrast media (CM)-enhanced examinations are increasing. The annual sale of iodine for CM now represents 60 million CM doses a year world-wide. In spite of improvements in chemical structure, CM are still the third leading cause of hospital-acquired acute renal failure. The definition of contrast nephropathy (CN) is discussed, as well as the mechanisms involved in the pathogenesis. Low osmolar contrast media (LOCM) are less nephrotoxic than high osomolar contrast media (HOCM) and cause fewer osmotoxic side-effects such as pain and heat sensations. The non-ionic dimeric contrast media which are iso-osmolar to plasma (IOCM) cause even fewer haemodynamic side-effects and result in better opacification of the urinary tract than LOCM. The nephrotoxicity of IOCM is low. The risk factors for CN and methods for prevention of CN are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11186471     DOI: 10.1080/003655900750048341

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  20 in total

1.  Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation.

Authors:  Peter Bernhardt; Christoph Rodewald; Julia Seeger; Birgid Gonska; Dominik Buckert; Michael Radermacher; Vinzenz Hombach; Wolfgang Rottbauer; Jochen Wöhrle
Journal:  Clin Res Cardiol       Date:  2015-09-22       Impact factor: 5.460

2.  Joint quality improvement guidelines for pediatric arterial access and arteriography: from the Societies of Interventional Radiology and Pediatric Radiology.

Authors:  Manraj K S Heran; Francis Marshalleck; Michael Temple; Clement J Grassi; Bairbre Connolly; Richard B Towbin; Kevin M Baskin; Josee Dubois; Mark J Hogan; Sanjoy Kundu; Donald L Miller; Derek J Roebuck; Steven C Rose; David Sacks; Manrita Sidhu; Michael J Wallace; Darryl A Zuckerman; John F Cardella
Journal:  Pediatr Radiol       Date:  2010-02

3.  Development of contrast-induced nephropathy in subarachnoid hemorrhage: a single center perspective.

Authors:  Bappaditya Ray; Kim L Rickert; Babu G Welch; Jonathan A White; Daniel R Klinger; Benjamin P Boudreaux; Brett A Whittemore; Eugene Gu
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

4.  Feasibility of 320-row area detector CT coronary angiography using 40 mL of contrast material: assessment of image quality and diagnostic accuracy.

Authors:  Rihyeon Kim; Eun-Ah Park; Whal Lee; Jin Wook Chung
Journal:  Eur Radiol       Date:  2016-02-23       Impact factor: 5.315

5.  Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.

Authors:  Jing Wang; Xiaobo Ai; Li Li; Yanyan Gao; Nina Sun; Changgui Li; Weihong Sun
Journal:  Int Urol Nephrol       Date:  2017-06-27       Impact factor: 2.370

6.  Screening for renal insufficiency following ESUR (European Society of Urogenital Radiology) guidelines with on-site creatinine measurements in an outpatient setting.

Authors:  H P Ledermann; B Mengiardi; A Schmid; J M Froehlich
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

7.  Three-Dimensional Kidney-on-a-Chip Assessment of Contrast-Induced Kidney Injury: Osmolality and Viscosity.

Authors:  Kipyo Kim; Beomgyun Jeong; Yun-Mi Lee; Hyung-Eun Son; Ji-Young Ryu; Seokwoo Park; Jong Cheol Jeong; Ho Jun Chin; Sejoong Kim
Journal:  Micromachines (Basel)       Date:  2022-04-28       Impact factor: 3.523

Review 8.  [Iodinated contrast agent-induced nephropathy].

Authors:  C Erley
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

9.  Detecting the pulmonary trunk in CT scout views using deep learning.

Authors:  Aydin Demircioğlu; Magdalena Charis Stein; Moon-Sung Kim; Henrike Geske; Anton S Quinsten; Sebastian Blex; Lale Umutlu; Kai Nassenstein
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

10.  The role of inflammation in contrast-induced nephropathy.

Authors:  E A Kwasa; S Vinayak; R Armstrong
Journal:  Br J Radiol       Date:  2014-07-10       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.